Acorda Therapeutics, Inc. Operating Lease Liability
Acorda Therapeutics, Inc. had Operating Lease Liability of $4.45 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-05-14
- 2024-03-31: Operating Lease, Liability $4.45M.
- 2023-12-31: Operating Lease, Liability $4.75M.
- 2023-09-30: Operating Lease, Liability $5.04M.
- 2023-06-30: Operating Lease, Liability $5.33M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2024-03-31 | $4.45M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.75M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $5.04M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.33M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.61M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.89M 10-K · filed 2023-03-15 | |
| 2022-09-30 | $6.07M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.24M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.91M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $12.27M 10-K · filed 2022-03-18 | |
| 2021-06-30 | $14.75M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $16.01M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $25.14M 10-K · filed 2021-03-16 | |
| 2020-09-30 | $13.60M 10-Q · filed 2021-11-12 | $26.64M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $28.17M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $29.60M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $30.74M 10-K · filed 2020-02-28 | |
| 2019-09-30 | $32.09M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $33.41M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $33.91M 10-Q · filed 2019-05-07 |